PortfoliosLab logo

CARsgen Therapeutics Holdings Ltd (2171.HK)

Equity · Currency in HKD · Last updated May 31, 2023

Company Info

ISINKYG1996C1006
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$6.34B
EPSHK$0.00
PE RatioN/A
PEG RatioN/A
Revenue (TTM)HK$25.81M
Gross Profit (TTM)HK$25.81M
EBITDA (TTM)-HK$748.73M
Year RangeHK$9.20 - HK$21.85
Target PriceHK$22.68

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in CARsgen Therapeutics Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%2023FebruaryMarchAprilMay
-18.89%
2.09%
2171.HK (CARsgen Therapeutics Holdings Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 2171.HK

CARsgen Therapeutics Holdings Ltd

Return

CARsgen Therapeutics Holdings Ltd had a return of -26.03% year-to-date (YTD) and 3.55% in the last 12 months. Over the past 10 years, CARsgen Therapeutics Holdings Ltd had an annualized return of -40.85%, outperforming the S&P 500 benchmark which had an annualized return of -2.30%.


PeriodReturnBenchmark
1 month-9.92%-0.57%
Year-To-Date-26.03%7.49%
6 months-17.31%4.74%
1 year3.55%-4.19%
5 years (annualized)-40.85%-2.30%
10 years (annualized)-40.85%-2.30%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202324.30%-15.04%-19.72%-3.15%
202219.06%4.23%8.55%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for CARsgen Therapeutics Holdings Ltd (2171.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
2171.HK
CARsgen Therapeutics Holdings Ltd
-0.02
^GSPC
S&P 500
0.17

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current CARsgen Therapeutics Holdings Ltd Sharpe ratio is -0.02. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.200.402023FebruaryMarchAprilMay
-0.02
0.10
2171.HK (CARsgen Therapeutics Holdings Ltd)
Benchmark (^GSPC)

Dividend History


CARsgen Therapeutics Holdings Ltd doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%2023FebruaryMarchAprilMay
-79.67%
-12.20%
2171.HK (CARsgen Therapeutics Holdings Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the CARsgen Therapeutics Holdings Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the CARsgen Therapeutics Holdings Ltd is 82.39%, recorded on Oct 12, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.39%Oct 4, 2021253Oct 12, 2022
-32.05%Jul 13, 202112Jul 28, 202112Aug 13, 202124
-16.46%Sep 6, 20216Sep 13, 20217Sep 23, 202113
-12.82%Aug 16, 20215Aug 20, 20213Aug 25, 20218
-6.77%Jun 25, 20217Jul 6, 20213Jul 9, 202110

Volatility Chart

The current CARsgen Therapeutics Holdings Ltd volatility is 16.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%2023FebruaryMarchAprilMay
16.89%
3.55%
2171.HK (CARsgen Therapeutics Holdings Ltd)
Benchmark (^GSPC)